DuoGenic StemCells

DuoGenic StemCells Corporation is a Taiwan-based biotechnology company specializing in the development and manufacture of high-quality stem cell culture media and cell therapy products. Founded in 2018 and listed on the Taipei Exchange, the company provides clinical-grade media such as AllPhase for mesenchymal stem cell (MSC) expansion and DuoESy for human pluripotent stem cells (hPSC). DuoGenic also advances its own therapeutic pipeline, including blood cell therapies and MSC-based treatments for degenerative diseases and spinal cord injury. The company operates a GMP-certified facility and focuses on standardizing stem cell cultivation to support the global regenerative medicine market. Their products are widely used by universities, research institutes, and other biotech firms for advanced cell therapy development.